Ikarian-Capital

AI_NATIVE detailed information: This accession holds the following tickers:[
  "AKRO",
  "EWTX",
  "TRVI",
  "NKTR",
  "INSM",
  "FBRX",
  "TGTX",
  "APLS",
  "ALNY",
  "ARCT",
  "DNA",
  "SWTX",
  "RCKT",
  "SGMO",
  "ARVN",
  "ALT",
  "RCUS",
  "OLMA",
  "GPCR",
  "RLAY",
  "THRD",
  "TERN",
  "TRML",
  "NUVB",
  "TYRA",
  "MNMD",
  "TECX",
  "LRMR",
  "MLYS",
  "KYMR",
  "NMRA",
  "ABEO",
  "KROS",
  "GLUE",
  "PRTA",
  "ABOS",
  "ANRO",
  "ALEC",
  "ALLK",
  "AVTX",
  "JANX",
  "ANEB",
  "PHGE",
  null,
  "GERN",
  "SRRK",
  "FULC",
  "APGE",
  "TARS",
  "TKNO",
  "INBX",
  "JSPR",
  "MGNX",
  "LXEO",
  "LYEL",
  null,
  "MNPR",
  null,
  "STIM",
  "OKUR",
  "PYXS",
  "RLMD",
  "SGMT",
  "SNSE",
  "SYBX",
  "CYBN",
  null,
  "AEMD",
  "TOVX",
  "RZLT",
  "ACRS",
  "ACOG",
  "INCY",
  "TEVA",
  "SPY",
  "PTGX",
  "PEPG",
  "TRAW",
  "RNA",
  "SLDB",
  "PRAX",
  "LXRX",
  "LYRA",
  "MLTX",
  "IBIO",
  "EVAX",
  "SLNO",
  "ACLX",
  "QURE",
  "RNAC",
  "ETNB",
  "DYN",
  "SPRB",
  "SRPT",
  "CHRO",
  null,
  null,
  "CRVS",
  "CDTX",
  "ELDN",
  "ELEV",
  "ELVN",
  "DCTH",
  "EOLS",
  "IMUX",
  "HROW",
  "HOOK",
  "ITOS",
  "KPTI",
  "KOD",
  "KZR",
  "VRNA",
  "VERU",
  "VTYX",
  "VERV",
  "VTGN",
  "VKTX",
  "VIR",
  "VIGL",
  "VRDN",
  "VYGR",
  "ORKA",
  "BHVN",
  "TRUP",
  "TDOC",
  "RARE",
  "IMVT",
  "PCVX",
  "BPMC",
  "BBIO",
  "CAPR",
  "CELC",
  "CPRX",
  "CLDX",
  "CMPX",
  "CORT",
  "CRNX",
  "CPIX",
  "CYTK",
  "IRON",
  "LLY"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 141
Total Value: 710178588
Accession Number: 0001420506-25-001276
Form Type: 13F-HR
CIK: ikarian-capital
Manager Name: Ikarian-Capital

Data Enrichment

96% identified

135 identified6 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

141 positions • $710.2M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 6 of 8

Sort by:

Lyell Immunopharma, Inc.

LYEL|55083R104

Shares:876.0K

Value:$471.3K

% of Portfolio:0.1% ($471.3K/$710.2M)

iTeos Therapeutics, Inc.

ITOS|46565G104

Shares:78.6K

Value:$469.2K

% of Portfolio:0.1% ($469.2K/$710.2M)

Vigil Neuroscience, Inc.

VIGL|92673K108

Shares:250.0K

Value:$445.0K

% of Portfolio:0.1% ($445.0K/$710.2M)

AETHLON MEDICAL INC

AEMD|00808Y406

Shares:1.2M

Value:$440.1K

% of Portfolio:0.1% ($440.1K/$710.2M)

Alto Neuroscience, Inc.

ANRO|02157Q109

Shares:175.0K

Value:$378.0K

% of Portfolio:0.1% ($378.0K/$710.2M)

Mind Medicine (MindMed) Inc.

MNMD|60255C885

Shares:62.7K

Value:$366.7K

% of Portfolio:0.1% ($366.7K/$710.2M)

Third Harmonic Bio, Inc.

THRD|88427A107

Shares:100.0K

Value:$347.0K

% of Portfolio:0.0% ($347.0K/$710.2M)

Ginkgo Bioworks Holdings, Inc.

DNA|37611X209

Shares:58.3K

Value:$332.3K

% of Portfolio:0.0% ($332.3K/$710.2M)

Tyra Biosciences, Inc.

TYRA|90240B106

Shares:35.0K

Value:$325.5K

% of Portfolio:0.0% ($325.5K/$710.2M)

Celldex Therapeutics, Inc.

CLDX|15117B202

Shares:17.8K

Value:$323.1K

% of Portfolio:0.0% ($323.1K/$710.2M)

Acumen Pharmaceuticals, Inc.

ABOS|00509G209

Shares:265.8K

Value:$292.3K

% of Portfolio:0.0% ($292.3K/$710.2M)

Cartesian Therapeutics, Inc.

RNAC|816212302

Shares:22.2K

Value:$292.1K

% of Portfolio:0.0% ($292.1K/$710.2M)

SPRUCE BIOSCIENCES, INC.

SPRB|85209E109

Shares:1.0M

Value:$290.1K

% of Portfolio:0.0% ($290.1K/$710.2M)

Allakos Inc.

ALLK|01671P100

Shares:1.2M

Value:$266.7K

% of Portfolio:0.0% ($266.7K/$710.2M)

GERON CORP

GERN|374163103

Shares:150.0K

Value:$238.5K

% of Portfolio:0.0% ($238.5K/$710.2M)

16385C104

Shares:213.1K

Value:$232.2K

% of Portfolio:0.0% ($232.2K/$710.2M)

Aclaris Therapeutics, Inc.

ACRS|00461U105

Shares:150.9K

Value:$230.9K

% of Portfolio:0.0% ($230.9K/$710.2M)

Monopar Therapeutics

MNPR|61023L207

Shares:5.9K

Value:$215.1K

% of Portfolio:0.0% ($215.1K/$710.2M)

28658R106

Shares:175.1K

Value:$213.6K

% of Portfolio:0.0% ($213.6K/$710.2M)

PepGen Inc.

PEPG|713317105

Shares:150.0K

Value:$210.8K

% of Portfolio:0.0% ($210.8K/$710.2M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Lyell Immunopharma, Inc.(LYELcusip55083R104)	876.0K	QoQ -31.34% (-400.0K) YoY NEW(+876.0K)	All Managers (Combined)	$471.3K	0.1% ($471.3K/$710.2M)	QoQ -42.28% (-$345.4K) YoY NEW(+$471.3K)
iTeos Therapeutics, Inc.(ITOScusip46565G104)	78.6K	QoQ 0.00% (-0) YoY -22.44% (-22.7K)	All Managers (Combined)	$469.2K	0.1% ($469.2K/$710.2M)	QoQ -22.26% (-$134.4K) YoY -66.05% (-$912.9K)
Vigil Neuroscience, Inc.(VIGLcusip92673K108)	250.0K	QoQ -50.00% (-250.0K) YoY NEW(+250.0K)	All Managers (Combined)	$445.0K	0.1% ($445.0K/$710.2M)	QoQ -47.64% (-$405.0K) YoY NEW(+$445.0K)
AETHLON MEDICAL INC(AEMDcusip00808Y406)	1.2M	QoQ +63.90% (-479.3K) YoY NEW(+1.2M)	All Managers (Combined)	$440.1K	0.1% ($440.1K/$710.2M)	QoQ -31.77% (-$204.9K) YoY NEW(+$440.1K)
Alto Neuroscience, Inc.(ANROcusip02157Q109)	175.0K	QoQ -50.00% (-175.0K) YoY NEW(+175.0K)	All Managers (Combined)	$378.0K	0.1% ($378.0K/$710.2M)	QoQ -74.46% (-$1.1M) YoY NEW(+$378.0K)
Mind Medicine (MindMed) Inc.(MNMDcusip60255C885)	62.7K	QoQ 0.00% (-0) YoY -78.92% (-234.8K)	All Managers (Combined)	$366.7K	0.1% ($366.7K/$710.2M)	QoQ -15.94% (-$69.6K) YoY -86.88% (-$2.4M)
Third Harmonic Bio, Inc.(THRDcusip88427A107)	100.0K	QoQ 0.00% (-0) YoY NEW(+100.0K)	All Managers (Combined)	$347.0K	0.0% ($347.0K/$710.2M)	QoQ -66.27% (-$682.0K) YoY NEW(+$347.0K)
Ginkgo Bioworks Holdings, Inc.(DNAcusip37611X209)	58.3K	QoQ -92.42% (-711.4K) YoY NEW(+58.3K)	All Managers (Combined)	$332.3K	0.0% ($332.3K/$710.2M)	QoQ -95.60% (-$7.2M) YoY NEW(+$332.3K)
Tyra Biosciences, Inc.(TYRAcusip90240B106)	35.0K	QoQ -41.66% (-25.0K) YoY +6886.02% (+34.5K)	All Managers (Combined)	$325.5K	0.0% ($325.5K/$710.2M)	QoQ -60.97% (-$508.5K) YoY +3861.78% (+$317.3K)
Celldex Therapeutics, Inc.(CLDXcusip15117B202)	17.8K	QoQ -91.33% (-187.7K) YoY NEW(+17.8K)	All Managers (Combined)	$323.1K	0.0% ($323.1K/$710.2M)	QoQ -93.77% (-$4.9M) YoY NEW(+$323.1K)
Acumen Pharmaceuticals, Inc.(ABOScusip00509G209)	265.8K	QoQ 0.00% (-0) YoY -0.24% (-666)	All Managers (Combined)	$292.3K	0.0% ($292.3K/$710.2M)	QoQ -36.04% (-$164.8K) YoY -72.90% (-$786.7K)
Cartesian Therapeutics, Inc.(RNACcusip816212302)	22.2K	QoQ -57.50% (-30.0K) YoY NEW(+22.2K)	All Managers (Combined)	$292.1K	0.0% ($292.1K/$710.2M)	QoQ -68.73% (-$642.1K) YoY NEW(+$292.1K)
SPRUCE BIOSCIENCES, INC.(SPRBcusip85209E109)	1.0M	QoQ 0.00% (-0) YoY NEW(+1.0M)	All Managers (Combined)	$290.1K	0.0% ($290.1K/$710.2M)	QoQ -30.92% (-$129.9K) YoY NEW(+$290.1K)
Allakos Inc.(ALLKcusip01671P100)	1.2M	QoQ +20.57% (-200.0K) YoY +25.65% (-239.3K)	All Managers (Combined)	$266.7K	0.0% ($266.7K/$710.2M)	QoQ -77.31% (-$909.3K) YoY -77.30% (-$908.4K)
GERON CORP(GERNcusip374163103)	150.0K	QoQ NEW(+150.0K) YoY NEW(+150.0K)	All Managers (Combined)	$238.5K	0.0% ($238.5K/$710.2M)	QoQ NEW(+$238.5K) YoY NEW(+$238.5K)
(cusip16385C104)✕	213.1K	QoQ 0.00% (-0) YoY -0.15% (-340)	All Managers (Combined)	$232.2K	0.0% ($232.2K/$710.2M)	QoQ -39.77% (-$153.4K) YoY +39.69% (-$66.0K)
Aclaris Therapeutics, Inc.(ACRScusip00461U105)	150.9K	QoQ -56.88% (-199.1K) YoY NEW(+150.9K)	All Managers (Combined)	$230.9K	0.0% ($230.9K/$710.2M)	QoQ -73.40% (-$637.1K) YoY NEW(+$230.9K)
Monopar Therapeutics(MNPRcusip61023L207)	5.9K	QoQ 0.00% (+0) YoY NEW(+5.9K)	All Managers (Combined)	$215.1K	0.0% ($215.1K/$710.2M)	QoQ +65.50% (+$85.1K) YoY NEW(+$215.1K)
(cusip28658R106)✕	175.1K	QoQ 0.00% (-0) YoY NEW(+175.1K)	All Managers (Combined)	$213.6K	0.0% ($213.6K/$710.2M)	QoQ -32.22% (-$101.6K) YoY NEW(+$213.6K)
PepGen Inc.(PEPGcusip713317105)	150.0K	QoQ NEW(+150.0K) YoY NEW(+150.0K)	All Managers (Combined)	$210.8K	0.0% ($210.8K/$710.2M)	QoQ NEW(+$210.8K) YoY NEW(+$210.8K)